Biophysical and functional characterization of hippocalcin mutants responsible for human dystonia by Helassa, N et al.
1 
 
Biophysical and functional characterization of hippocalcin mutants responsible for human dystonia 
 
Nordine Helassa1*, Svetlana V. Antonyuk2, Lu-Yun Lian3, Lee P. Haynes1 and Robert D. Burgoyne1 
 
 
1Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool 
L69 3BX, United Kingdom. 2Molecular Biophysics Group, Institute of Integrative Biology, Faculty of Health and Life Sciences, 
University of Liverpool, Liverpool L69 7ZB, United Kingdom. 3NMR Centre for Structural Biology, Institute of Integrative 
Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L69 7ZB, United Kingdom.  
 
*Corresponding author: nhelassa@liverpool.ac.uk 
 
 
 
  
2 
 
Materials and Methods 
 
Determination of hippocalcin proteins stability. Trypsin limited proteolysis. Biotinylated hippocalcin proteins (20 g/ml) 
were incubated with trypsin (0.5 g/ml) for 0, 5, 10, 15, 20 and 30 min at 37 °C. The reaction was stopped using 5 mM PMSF. 
Degradation of hippocalcin was quantified by western blot (streptavidin-HRP conjugate) using ImageJ software. 
Heat denaturation. Heat stability of hippocalcin proteins was determined by following the unfolding of the -helices at 222 
nm using circular dichroism (JASCO J-1100 CD spectrometer, 200 l quartz cuvette, 0.1 cm path length). Samples (15 M) 
were measured in MilliQ water containing either 1 mM CaCl2 or 5 mM EGTA. Data was collected from 20 to 90 °C using 1 
°C increment and a ramp increase of 5°C/min. 
Guanidine denaturation. Chemical stability of hippocalcin proteins was determined by measuring the intrinsic tryptophan 
fluorescence after guanidine denaturation (JASCO FP-6300 fluorimeter, 1 mL quartz cuvette). Proteins (~ 10 M) in 50 mM 
K+-HEPES, 100 mM KCl, 2 mM MgCl2, pH 7.5, mixed with increasing concentration of guanidine ([Gnd-HCl] from 0 to 3 
M). Proteins were excited at 280 nm and fluorescence emission spectra were collected from 290 to 410 nm. 
Structure determination of hippocalcin proteins. Circular dichroism (CD) spectroscopy. CD spectra were recorded using a 
JASCO J-1100 spectrometer equipped with a JASCO MCB-100 mini circulation bath for temperature control. Far-UV CD 
spectra (180-260 nm) were recorded at 20 °C in a 0.1 cm path length quartz cell (5 accumulations, scan rate 50 nm.min-1). 
Proteins (15 M) were measured in MilliQ water containing either 1 mM CaCl2 or 5 mM EGTA. Secondary structure content 
was determined using CDSSTR prediction algorithm (DichroWeb online server) (1, 2). 
Oligomerisation of hippocalcin proteins. In vitro crosslinking. Hippocalcin purified proteins (10-20 M) were crosslinked 
using 20-50 fold molar excess of DSP or BS3 crosslinker (ThermoScientific) in the presence of 0.05-0.1-0.5-1 mM CaCl2 or 5 
mM EGTA. The mixture was incubated at room temperature for 30 min and the reaction was quenched by the addition of 50 
mM Tris for 10 min. 
In vivo crosslinking. N2A cells were grown on a 6-well plate in DMEM supplemented with 5% fetal bovine serum, 1x non-
essential amino-acids and 1% Penicillin-Streptomycin solution. At 90% confluence, cells were transfected using 
Lipofectamine™ 2000 (Invitrogen) following the manufacturer’s recommendations. Crosslinking was performed 24 hours 
post-transfection by washing the cells with PBS and incubated with 2 mM DSP for 30 min. After the reaction was stopped by 
50 mM Tris for 10 min, the cells were lysed in RIPA buffer for 30 min at 4°C. Clarified lysates were loaded on SDS-PAGE 
(NuPAGE 4-12% Bis-Tris, NuPAGE MOPS SDS running buffer, Life Technologies) with or without pre-incubation with a 
reducing agent to cleave the crosslinker (50 mM DTT for 30 min at 37°C), for Western blot analysis using anti-GFP monoclonal 
antibody (Roche) and densitometry quantification. 
Translocation experiment using photo-release/confocal imaging. Hippocalcin exhibits a Ca2+/myristoyl switch mechanism 
which allow the protein to remain cytosolic at resting calcium and to translocate to cellular membranes when intracellular 
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calcium concentration increases (10). SH-SY5Y cells transfected with hippocalcin-mCherry constructs were loaded with 1 M 
Fluo-4-AM (Molecular Probes) and 25 M NP-EGTA (Molecular Probes) and incubated in growth medium for 30 min at 37 
°C. Cells were examined in a 35-mm glass bottom dish (MatTek) with a 3i Marianas spinning-disk confocal microscope 
equipped with a Zeiss AxioObserver Z1, a 63x/1.4 oil immersion objective and a 3i Laserstack as excitation light source (405 
nm, for NP-EGTA photolysis; 488 nm, for Fluo-4; 561 nm, for hippocalcin-mCherry). Emitted light was collected through 
single bandpass filters (Yokogawa CSU-X filter wheel) onto a CMOS camera (Hamamatsu, ORCA Flash 4.0; 1152x1656 
pixels).  Experiments were carried out at 37 °C (OKO lab incubation chamber) and images were collected at 2 frames/s. To 
investigate the calcium-dependent translocation of hippocalcin, photolysis of NP-EGTA was performed by illumination with 
405-nm laser light at 10% power for 1 ms for rapid release of [Ca2+]. The time course for intracellular calcium release and 
hippocalcin translocation after photo-stimulation was monitored at the trans-Golgi network (TGN) over an elliptical region of 
interest (ROI). The mean background fluorescence was measured by ROI with the same dimensions placed at a point at which 
no cell was present. Fluo-4 and hippocalcin fluorescence changes were obtained from the background-corrected fluorescence 
with ImageJ program. Data obtained from 10 cells was normalised and plotted on GraphPad. 
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Figure S1. Verification of [Ca2+] used for hippocalcin equilibrium titrations with OGB-1. A Kd value of 132 ± 11 nM was 
obtained, not significantly different from reported by Molecular Probes (170 M in buffer without magnesium). 
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Figure S2. Effect of dystonia-causing mutations on trypsin, temperature and chemical susceptibility of hippocalcin. (a) Trypsin 
limited proteolysis of hippocalcin wild-type and mutants. Western blots of purified hippocalcin proteins were incubated with 
trypsin for 0, 5, 10, 15, 20 and 30 minutes at 37 °C. Bands were quantified by densitometry using ImageJ software. (b) Thermal 
unfolding of hippocalcin wild-type and mutants monitored by circular dichroism recorded at 222 nm from 20 to 90 °C. (c) 
Typical tryptophan emission spectra of hippocalcin and denaturation-induced fluorescence of hippocalcin wild-type and 
mutants as a function of [Gnd-HCl] (left panel). Quantification of the emission fluorescence at 340 nm as a function of Gnd-
HCl concentration did not show any significant difference between the wild-type and the mutants (right panel). 
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Figure S3. Analysis of the secondary structures of hippocalcin wild-type and mutants using circular dichroism (CD) 
spectroscopy. (a) CD spectra were obtained in the presence of 5 mM EGTA (left panel) or 1 mM CaCl2 (right panel) and (b) 
protein secondary structure content was estimated using CDSSTR method (Johnson (1999); Whitmore and Wallace (2004)) 
showing no significant difference between hippocalcin wild-type and the mutants. 
 
7 
 
 
Figure S4. Secondary and crystal structure of hippocalcin, hippocalcin(T71N) and hippocalcin(A190T). (a) Amino-acid and 
secondary structure alignment of full-length human hippocalcin and rat NCS-1. Positions of the dystonia-causing mutations are 
shown with a star. (b) Cartoon representation of the crystal packing of hippocalcin showing the long parallel protein fibrils 
morphology. (c) Alignment of hippocalcin crystal structure (magenta) with hippocalcin(T71N) (marine) and 
hippocalcin(A190T) (salmon) did not show any significant difference. Cartoon representation of the (d) hippocalcin(A190T) 
and (e) hippocalcin(T71N) structure. Details of the mutation site are shown as sticks. C-terminus is labelled with letter C, N-
terminus – N. Ca2+ ions in EF-2, EF-3 and EF-4 are shown as orange spheres.  
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Figure S5. Calcium-dependent oligomerisation of hippocalcin. (a) SDS-PAGE of hippocalcin purified proteins after in vitro 
crosslinking using BS3 crosslinker showing oligomer formation in the presence of calcium. Lane 1: molecular weight ladder, 
lane 2,6: hippocalcin wild-type, lane 3,7: hippocalcin(T71N), lane 4,8: hippocalcin(A190T), lane 2-4: in the presence of 5 mM 
EGTA, lane 6-8: in the presence of 1 mM CaCl2. (b) SDS-PAGE of hippocalcin purified proteins after in vitro crosslinking 
using DSP crosslinker showing oligomer formation in the presence of calcium. Lane 1: molecular weight ladder, lane 2,6,9: 
hippocalcin wild-type, lane 3,7,10: hippocalcin(T71N), lane 4,8,11: hippocalcin(A190T), lane 2-4: in the presence of 5 mM 
EGTA, lane 6-8: in the presence of 1 mM CaCl2, lane 9-11: in the presence of 1 mM CaCl2 and 50 mM DTT (left panel). Bands 
were quantified by densitometry using ImageJ (right panel). Light colors in the absence of calcium, dark colors in the presence 
of calcium. (c) Dimeric fraction of hippocalcin wild-type purified protein after in vitro crosslinking using DSP at [Ca2+] of 50 
M, 100 M, 500 M and 1 mM. Crosslink reactions were run on SDS-PAGE and analysed by densitometry using ImageJ. 
Data were normalised to the dimeric fraction obtained at 1 mM [Ca2+] and showed that 50 M [Ca2+] was sufficient to induce 
oligomer formation. (d) Western blot of in vivo crosslinking of N2A cells transfected with EGFP-hippocalcin using DSP 
showing that oligomerisation occurs at physiological conditions. Lane 1: molecular weight ladder, lane 3,7: hippocalcin wild-
type, lane 4,8: hippocalcin(T71N), lane 5,9: hippocalcin(A190T), lane 3-5: in the presence of 50 mM DTT, lane 7-9: in the 
absence of DTT. 
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Figure S6. Expression level of transfected SH-SY5Y cells with mCherry tagged hippocalcin (RFP antibody). Lane 1: molecular 
weight ladder, lane 2: hippocalcin wild-type, lane 3: hippocalcin(T71N), lane 4: hippocalcin(A190T). Calnexin, tubulin and 
actin antibodies used as loading controls showed that expression levels were similar for all hippocalcin proteins. 
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Figure S7. Rapid translocation of hippocalcin wild-type and dystonia-causing mutants after flash photolysis of NP-EGTA. SH-
SY5Y cells transfected with hippocalcin-mCherry constructs were loaded with the calcium dye Fluo-4 and the calcium chelator 
NP-EGTA. After rapid calcium photorelease, live cells were imaged on a spinning-disk confocal microscope (n = 30). (a) 
Representative microscopy images before and after calcium photorelease revealed no significant alteration of translocation 
properties. Arrows indicate the location of the translocated hippocalcin after calcium photorelease. (b) Time course of 
intracellular calcium increase followed by Fluo-4 and hippocalcin translocation, showing that translocation occurs when 
intracellular calcium increases. Scale bar = 10 m. 
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Table S1.  Data collection and refinement statistics.  
Values in parentheses are for the highest resolution shell.  
 
 
  
 
 
HPCA HPCA A190T HPCA T71N 
Data collection 
Wavelength (Å) 
0.98 0.92 0.98 
Beamline  IO2 IO4 IO4-1 
Detector Pilatus Pilatus Pilatus 
Space group P61 P61 P61 
Unit-cell dimensions 
(a,b,c) (Å) 
50.91, 50.91, 283.02 50.66,   50.66,  283.46 51.16,   51.16,  284.06 
Resolution (Å) 43.56-2.42 (2.59-2.42) 43.87-2.54 (2.6-2.54) 47.3-3.00 (3.18-3.00) 
Rmerge % (last shell) 4.4  (63.0) 8.6(68) 12.8(57) 
I/σ (last shell) 11.7 (1.8) 8.7(1.9) 4.9(1.6) 
Completeness (%) 98.8 (99.9) 99.7(99.6) 99.0(99.0) 
Redundancy 3.3 (3.2) 4.6(4.4) 2.7(2.7) 
Wilson  B factor (Å2) 62 56 62 
No. of reflections 15734 13592 8283 
 
Rwork/Rfree 
 
23.3/27.1 21.9/24.9 21.9/28.3 
No. of atoms 
Protein 2996 2996 3021 
Ca ions 6 6 6 
Water 34 34 22 
B factor (Å2) 
Protein 57.8 55 78 
Ca2+ ions EF-2 75 73 83 
Ca2+ ions EF-3 83 77 85 
Ca2+ ions EF-4 105 71 78 
Waters 65 50 47 
R.M.S deviations 
Bond length (Å) 0.014 0.012 0.008 
Bond angles (°) 1.98 1.5 1.14 
PDB code  5g4p 5g58 5m6c 
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Table S2. Molar mass calculated from MALS data for HPCA and HPCA mutants in the presence or absence of calcium 
 
 
Molar mass (kDa) Molar mass (kDa) 
in the presence of 5 mM EGTA in the presence of 1 mM CaCl2 
Peak 1 Peak 2 Peak 3 Peak 4 Peak 1 Peak 2 Peak 3 Peak 4 
HPCA 23.1 ± 0.2 45.5 ± 3.1 - - 25.1 ± 0.9 46.7 ± 1.1 68.2 ± 1.9 91.6 ± 2.9 
HPCA T71N 23.4 ± 0.3 34.5  ± 8.1 - - 24.1 ± 0.8 47.0  ± 0.2 65.7  ± 2.3 - 
HPCA N75K 23.0 ± 0.2 - - - 22.5 ± 0.9 42.8  ± 1.9 65.9  ± 1.9 - 
HPCA A190T 22.9 ± 0.2 44.8  ± 0.5 - - 23.8 ± 0.2 44.5  ± 1.1 63.9  ± 0.6 - 
 
 
 
 
